Trial Profile
Phase 2 randomized trial of a moxifloxacin-containing regimen for treatment of smear-positive pulmonary tuberculosis in adults with and without HIV infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2013
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary) ; Ethambutol; Isoniazid; Pyrazinamide; Rifampicin
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 26 Mar 2013 Lead trial centre (Johns Hopkins University) added as reported by ClinicalTrials.gov record.
- 04 Apr 2009 Primary endpoint 'Bacteriological eradication rate' has been met.
- 04 Apr 2009 Results have been reported in the Lancet.